| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
29,500,000 |
| Market
Cap: |
56.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.365 - $4.91 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cue Biopharma is a biopharmaceutical company engineering a class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body. Co. is focusing on drug product candidates for treating cancer in its CUE-100 series, which exploits rationally engineered interleukin 2, in context of the key Immuno- Selective Targeting and Alteration of T Cells framework for selective activation of targeted tumor-specific T cells. Co. is seeking third party support through partnerships and collaborations, or alternative funding structures, to further develop its programs outside of oncology, including its CUE-200, CUE-300 and CUE-400 series.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,000 |
240,000 |
| Total Buy Value |
$0 |
$0 |
$19,620 |
$836,320 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
9,325 |
| Total Sell Value |
$0 |
$0 |
$0 |
$30,586 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marlett Christopher A |
Director |
– • – |
2018-12-20 |
4 |
B |
$4.74 |
$44,736 |
I/I |
9,438 |
34,234 |
2.1 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-19 |
4 |
B |
$5.00 |
$2,000 |
I/I |
400 |
24,796 |
2.02 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-18 |
4 |
B |
$5.20 |
$19,053 |
I/I |
3,664 |
24,396 |
2.1 |
- |
|
| Digiandomenico Anthony |
Director |
– • – |
2018-12-17 |
4 |
B |
$5.48 |
$54,800 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-13 |
4 |
B |
$5.06 |
$50,600 |
I/I |
10,000 |
20,732 |
2.1 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-12 |
4 |
B |
$5.07 |
$16,168 |
I/I |
3,189 |
10,732 |
2.1 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-12 |
4 |
B |
$5.09 |
$45,810 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
| Marlett Christopher A |
Director |
– • – |
2018-12-11 |
4 |
B |
$4.86 |
$36,659 |
I/I |
7,543 |
7,543 |
2.1 |
- |
|
| Millar Kerri-Ann |
VP-Finance |
• – – |
2018-08-29 |
4 |
B |
$8.48 |
$8,480 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Passeri Daniel R |
CEO and President |
• • – |
2018-08-16 |
4 |
B |
$8.09 |
$48,510 |
D/D |
6,000 |
47,600 |
2.81 |
- |
|
| Passeri Daniel R |
CEO and President |
• • – |
2018-06-29 |
4 |
B |
$11.97 |
$19,152 |
D/D |
1,600 |
41,600 |
2.81 |
- |
|
| Pienta Kenneth |
Chief Medical Officer |
• – – |
2017-12-27 |
4 |
B |
$7.50 |
$15,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
112 Records found
|
|
Page 5 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.27 (12.39%) 
